MP Securities increased its price target on Horizon Pharma Inc (NASDAQ:HZNP) after the company preannounced higher than expected Q4 revenue. The firm expects the company’s 2014 revenue to surpass its guidance, and it reiterates an Outperform rating on the stock. Horizon Pharma Inc (NASDAQ:HZNP) stock opened at $8.85 in last trading session, and closed at $10.05, trading in the range of $8.48 – $10.52. The stock showed a positive weekly performance of 19.93%.
Shares of TherapeuticsMD Inc (NYSEMKT:TXMD) rose Tuesday after the company reported positive study results for a drug designed to treat symptoms of menopause. The company said women who took its drug, which is called Vagicap, had lower levels of the hormone estradiol in their bodies than patients who took Novo Nordisk’s drug Vagifem. Patients who used the Vagicap capsule had lower overall exposure to estradiol and lower peak levels as well. It said higher estradiol concentrations are associated with increased risk of side effects. TherapeuticsMD Inc (NYSEMKT:TXMD) shares closed at $6.24 on last trade day, by gaining 6.12%. Stock 52 week range is $1.65 – $6.48. Company’s market capitalization is $904.60 billion.
Biostar Pharmaceuticals Inc (NASDAQ:BSPM) is a holding company. The Company, through its wholly owned subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar) and its variable interest entity (VIE) Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical), develops, manufactures and markets pharmaceutical products for a variety of diseases and conditions in the People’s Republic of China. Biostar Pharmaceuticals Inc (NASDAQ:BSPM) stock decreased -5.74% and finished the last session at $1.97. The EPS of the stock remained -0.66. Company’s market capitalization is $24.32 billion.
After Aerie Pharmaceuticals Inc (NASDAQ:AERI)’s stock fell yesterday, RBC Capital sees no fundamental reason for the decline ,and thinks the weakness could provide a buying opportunity. The firm recommends buying the stock on any further pullbacks and keeps an Outperform rating on the shares. Aerie Pharmaceuticals Inc (NASDAQ:AERI) stock opened at $16.51 in last trading session and closed at $16.73. The 52 week range of the stock is $10.25 – $21.99 and the day range was $15.65 – $19.47.